Clinical Trial: A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Dyslipidemia
Study Type: INTERVENTIONAL
Official Title: A Phase IIb, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants With Dyslipidem
Brief Summary:
The primary purpose of this study is to measure the effect of different daily doses of AZD0780 on Low-Density Lipoprotein (LDL-C) levels compared with placebo in participants with dyslipidemia.The effect of AZD0780 versus placebo on other lipid parameters and inflammatory markers is also investigated.The concentration of AZD0780 in blood at specific timepoints is measured, and the safety and tolerability of AZD0780 will be evaluated.There is a follow-up after end of treatment, but expanded access is not…
Read more